Shares of Gilead Sciences (NASDAQ:GILD) saw unusually large options trading on Friday. Stock investors acquired 34,225 put options on the stock, AR Network reports. Gilead Sciences, Inc. (NASDAQ:GILD) shares after opening at $75.67 moved to $76.20 on last trade day and at the end of the day closed at $72.07. Company price to sales ratio in past twelve months was calculated as 9.87 and price to cash ratio as 51.86. Gilead Sciences, Inc. (NASDAQ:GILD) showed a negative weekly performance of -3.97%.
Ariad Pharmaceuticals (NASDAQ:ARIA) Insider Timothy P. Clackson unloaded 6,667 shares of the stock in a transaction dated Friday, March 21st. The shares were sold at an average price of $7.89, for a total transaction of $52,602.63. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -3.57% in last trading session and ended the day on $7.84. ARIA return on equity ratio is recorded as -105.40% and its return on assets is -74.30%. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) yearly performance is -60.22%.
Endocyte Inc. (Nasdaq:ECYT) stock skyrocketed over 130% yesterday after the Indiana-based biopharma won market approval for its first drug, a cancer therapeutic called “vintafolide.” Endocyte, Inc. (NASDAQ:ECYT) shares moved down 92.42% in last trading session and was closed at $28.17 while trading in range of $25.88 – $33.70 – Endocyte, Inc. (NASDAQ:ECYT) year to date (YTD) performance is 163.76%.
Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s shares dropped 2.39% to $3.71. The company on Mar. 17 reported financial results for the fourth quarter and year ended Dec. 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Inovio Pharmaceuticals Inc (NYSEMKT:INO) weekly performance is 5.43%. On last trading day company shares ended up $3.69. Inovio Pharmaceuticals Inc (NYSEMKT:INO) distance from 50-day simple moving average (SMA50) is 24.54%. Analysts mean target price for the company is $3.80.